TY - JOUR
KW - Immunotherapy (MIP vaccine)
KW - Clinical improvement
KW - Chemotherapy (WHO- MDT)
KW - Borderline leprosy
AU - Kamal R
AU - Pathak V
AU - Kumari A
AU - Natrajan M
AU - Katoch K
AU - Kar H K
AB - <p>The response of leprosy patients to chemotherapy (WHO-Multi Drug Therapy) though generally good and predictable, exhibits variations in a section of cases. Some cases show a dramatic response while others show a slower response such variations are a reflection of the immune status of the host. This article is protected by copyright. All rights reserved.</p>

BT - The British journal of dermatology
C1 - <p>http://www.ncbi.nlm.nih.gov/pubmed/27518926?dopt=Abstract</p>

CN - KAMAL 2016
DO - 10.1111/bjd.14971
J2 - Br. J. Dermatol.
LA - eng
N2 - <p>The response of leprosy patients to chemotherapy (WHO-Multi Drug Therapy) though generally good and predictable, exhibits variations in a section of cases. Some cases show a dramatic response while others show a slower response such variations are a reflection of the immune status of the host. This article is protected by copyright. All rights reserved.</p>

PY - 2016
T2 - The British journal of dermatology
TI - Addition of Mycobacterium indicus pranii (MIP) vaccine as an immunotherapeutic with standard chemotherapy in borderline leprosy: A double blind study to assess clinical improvement (A preliminary report).
SN - 1365-2133
ER -